Abstract

Vaccines substantially mitigated the impacts of the covid-19 pandemic worldwide, saving millions of lives. The pandemic has, however, left a substantial global prevalence of a post-viral syndrome, called post-covid-19 condition or long covid. Post-covid-19 condition is defined as persistent symptoms at three months from the onset of covid-19, with symptoms that have lasted for at least two months. At least 200 million individuals are affected, and the protective value of covid-19 vaccines remains uncertain, with reported estimates ranging from a 13% to a 52% reduction in risk. Most of these studies relied on self-reported symptoms of post-covid-19 condition rather than a clinical diagnosis using ICD-10 (international classification of diseases, 10th revision) coding.

Rights

This article is made freely available for personal use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage

Cite as

Sivan, M., Ormerod, M. & Maini, R. 2023, 'Does timely vaccination help prevent post-viral conditions?', The BMJ, 383, pp. 2633-2633. https://doi.org/10.1136/bmj.p2633

Downloadable citations

Download HTML citationHTML Download BIB citationBIB Download RIS citationRIS
Last updated: 18 January 2024
Was this page helpful?